Pediatric heart transplantation after declaration of cardiocirculatory death.
In three infants awaiting orthotopic cardiac transplantation, transplantation was successfully performed with the use of organs from donors who had died from cardiocirculatory causes. The three recipients had blood group O and were in the highest-risk waiting-list category. The mean age of donors was 3.7 days, and the mean time to death after withdrawal from life support was 18.3 minutes. The 6-month survival rate was 100% for the 3 transplant recipients and 84% for 17 control infants who received transplants procured through standard organ donation. The mean number of rejection episodes among the three infants during the first 6 months after surgery was 0.3 per patient, as compared with 0.4 per patient among the controls. Echocardiographic measures of ventricular size and function at 6 months were similar among the three infants and the controls (left ventricular shortening fraction, 43.6% and 44.9%, respectively; P=0.73). No late deaths (within 3.5 years) have occurred in the three infants, and they have had functional and immunologic outcomes similar to those of controls. Mortality while awaiting a transplant is an order of magnitude higher in infants than in adults, and donors who died from cardiocirculatory causes offer an opportunity to decrease this waiting-list mortality.
Boucek
Mark M
MM
Department of Pediatrics, Joe DiMaggio Children's Hospital, Hollywood, FL 33021, USA. mboucek@mhs.net
Mashburn
Christine
C
Dunn
Susan M
SM
Frizell
Rebecca
R
Edwards
Leah
L
Pietra
Biagio
B
Campbell
David
D
D001926:Brain Death; D003643:Death; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006323:Heart Arrest; D006330:Heart Defects, Congenital / Q000601:surgery; D016027:Heart Transplantation / Q000379:methods / Q000401:mortality; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011379:Prognosis; D015996:Survival Rate; D020458:Third-Party Consent; D013997:Time Factors; D014019:Tissue Donors; D009927:Tissue and Organ Procurement / Q000379:methods*; D016896:Treatment Outcome